Last Price
0.583
Today's Change
+0.018 (3.18%)
Day's Change
0.509 - 0.61
Trading Volume
170,627
Market Cap
1 Million
Shares Outstanding
2 Million
Avg Volume
500,661
Avg Price (50 Days)
0.72
Avg Price (200 Days)
4.83
PE Ratio
-0.02
EPS
-36.84
Earnings Announcement
13-Nov-2024
Previous Close
0.57
Open
0.56
Day's Range
0.5095 - 0.6103
Year Range
0.432 - 20.16
Trading Volume
170,627
1 Day Change
3.17%
5 Day Change
-2.83%
1 Month Change
0.00%
3 Month Change
-69.15%
6 Month Change
-88.15%
Ytd Change
-96.23%
1 Year Change
-94.75%
3 Year Change
-99.62%
5 Year Change
-99.86%
10 Year Change
-99.86%
Max Change
-99.86%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.